“Media experiences describe it like a loophole,” states Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s quite intentional policy.” Brunner has expressed disappointment about how some coverage from the increase of compounding GLP-1s conflates unlicensed pharmacies peddling copyright prescription drugs or study peptides with credentialed https://aneurinl764mqs6.ssnblog.com/profile